Approval Year
Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 19:31:41 GMT 2023
by
admin
on
Fri Dec 15 19:31:41 GMT 2023
|
Record UNII |
4U3D3YY81M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C61101
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
||
|
WHO-ATC |
J01XA02
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/17/1913
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
||
|
FDA ORPHAN DRUG |
631418
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
||
|
WHO-VATC |
QJ01XA02
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2998
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
TEICOPLANIN
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
57021
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
29687
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
CHEMBL2367892
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
Teicoplanin
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
61036-62-2
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
DTXSID4048642
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
SUB129950
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
X-16
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
DB06149
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
SUB04714MIG
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
5155
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
C1412
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
D017334
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
4U3D3YY81M
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY | |||
|
759183
Created by
admin on Fri Dec 15 19:31:41 GMT 2023 , Edited by admin on Fri Dec 15 19:31:41 GMT 2023
|
PRIMARY |
All of the following components must be present:
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
IV or IM route of admininstration.
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||